SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
45.53
+1.33 (3.01%)
Apr 26, 2024, 4:00 PM EDT - Market closed
SpringWorks Therapeutics Employees
SpringWorks Therapeutics had 227 employees on December 31, 2022. The number of employees increased by 51 or 28.98% compared to the previous year.
Employees
227
Change (1Y)
51
Growth (1Y)
28.98%
Revenue / Employee
$23,996
Profits / Employee
-$1,432,176
Market Cap
3.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 227 | 51 | 28.98% |
Dec 31, 2021 | 176 | 98 | 125.64% |
Dec 31, 2020 | 78 | 22 | 39.29% |
Dec 31, 2019 | 56 | 4 | 7.69% |
Dec 31, 2018 | 52 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 19,000 |
Sotera Health Company | 3,000 |
Oscar Health | 2,400 |
iRhythm Technologies | 2,000 |
10x Genomics | 1,259 |
Axonics | 797 |
Prestige Consumer Healthcare | 560 |
Iovance Biotherapeutics | 557 |
SWTX News
- 2 days ago - SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 9 days ago - SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 - GlobeNewsWire
- 7 weeks ago - SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN - GlobeNewsWire
- 2 months ago - SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors - GlobeNewsWire
- 2 months ago - SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 2 months ago - SpringWorks Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire
- 3 months ago - SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire